Cyberknife Robotic Radiosurgery System to be showcased at the ESTRO conference

Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the company will showcase the treatment planning capabilities of the CyberKnife(R) Robotic Radiosurgery System at the 10th Biennial European Society for Therapeutic Radiology and Oncology (ESTRO) Conference on Physics and Radiation Technology for Clinical Radiotherapy in Maastricht, The Netherlands.

The latest generation of the MultiPlan(R) Treatment Planning System provides the most comprehensive set of tools available for high-precision radiosurgery treatment planning. The CyberKnife System's planning capabilities also include Monte Carlo Dose Calculation, which produces results in minutes compared to what commonly requires hours or days with other systems.

"We strongly believe that these new capabilities will transform the treatment planning practice, specifically for the treatment of lung tumors," said Frederic Sottilini, Senior Director, Marketing, Accuray EMEA.

Clinical findings will be presented during the conference, including the results of a study presented by Erasmus MC-Daniel den Hoed Cancer Center that demonstrates the benefits of the dose calculations performed using the CyberKnife System's Monte Carlo Dose Calculation in the treatment of Non-Small Cell Lung Cancer.

Additionally a Lunch Symposium will be held on Monday, August 31 at 1:00 p.m. CET in room 04/05, where conference attendees can learn more about the versatility and precision of the CyberKnife System's treatment planning and delivery technologies.

"Medical physicists from renowned academic centers will contribute to the scientific quality of this symposium, which should gather physicists from all over Europe who are interested in learning more about the highly-sophisticated treatment planning techniques that are available," said Sottilini.